ApprovalTrail

Approval · Notice of Compliance 7015 · 1996

NANDRABOLIN: Notice of Compliance 7015

Issued February 2, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7015
Date
February 2, 1996
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Anabolic steroid

Products in this notice

BrandDINStatus today
NANDRABOLIN02177773—

Medicinal ingredients